Are we ready for Molecular Pathology?Created by:
Last year, I had the opportunity to attend the ASNO (Asian Society for Neuro-oncology) Conference. One of the notable highlights of the conference was the evolution of pathologic diagnosis. Gone are the days when pathologists solely rely on microscopic changes seen on a specimen. In the recent years, there have been significant advancements in utilization of biomarkers such as hormonal markers and molecular markers. Because of these advancements, the World Health Organization criteria for pathological diagnosis on tumors will be revised. It was reported that based on concensus, these criteria will now include molecular markers to define tumor grading and classification. Although testing for molecular markers is still not mandatory, once WHO criteria is revised, most doctors will have this done on a regular basis to prognosticate and identify tumor grading/classification. Of course there markers come with a price. In the Philippine setting, a lot of people would not be able to afford this and I am uncertain if the country's healthcare set-up is ready to catch up with these advances. Is your healthcare system ready for these changes?